Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 1.00 |
| ▸ | MMP8 | P22894 | 3/20 | 1.00 |
| ▸ | MMP14 | P50281 | 2/20 | 1.00 |
| ▸ | MMP1 | P03956 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiludronic Acid SCHEMBL3628467 | 0.98 | MMP2 (0.96) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL8607914 | 0.96 | MMP2 (0.92) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL2067280 | 0.89 | MMP2 (0.80) | MMP2MMP8MMP14MMP1HSD17B10 | |
| SCHEMBL17954020 | 0.89 | MMP2 (0.79) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL7159094 | 0.87 | MMP2 (0.77) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL2326547 | 0.87 | MMP2 (0.75) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL2323298 | 0.87 | MMP2 (0.75) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL8607912 | 0.86 | MMP2 (0.74) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL41053 | 0.82 | MMP1 (1.00) | MMP2MMP8MMP14MMP1HSD17B10 | |
| Tiludronic Acid SCHEMBL8610150 | 0.81 | MMP1 (0.96) | MMP2MMP8MMP14MMP1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16413 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| US-20260137780-A1 | MATERIALS AND METHODS FOR IMPROVED EXPANSION AND USES OF IMMUNE CELLS | JANSSEN BIOTECH INC (US) | 2026-05-21 | — | — | US | claimed |
| CN-122005812-A | Combined medicine composition for engineering modification of in vivo target cells | 瑞达信使(杭州)生物技术有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260102414-A1 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | SANIFIT THERAPEUTICS S A (ES) | 2026-04-16 | — | — | US | claimed |
| US-12569507-B2 | CAR T-cells for the treatment of bone metastatic cancer | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2026-03-10 | — | — | US | claimed |
| EP-4683668-A1 | COMPOSITIONS AND METHODS FOR TREATING TENDON AND BONE INJURIES | The United States Government as Represented by The Department of Veterans Affairs (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4684811-A1 | NOVEL TREATMENT REGIMEN AND METHODS IN BONE HEALING | Moroxite AB (SE) | 2026-01-28 | — | — | EP | claimed |
| US-20250295676-A1 | INOSITOL PHOSPHATE COMPOUNDS FOR USE IN TREATING, INHIBITING THE PROGRESSION, OR PREVENTING CARDIOVASCULAR CALCIFICATION | VIFOR (INTERNATIONAL) LTD. (CH) | 2025-09-25 | — | — | US | claimed |
| EP-3901283-B1 | THERAPEUTIC TREATMENT OF BREAST CANCER BASED ON C-MAF STATUS | INBIOMOTION SL (ES) | 2025-08-06 | — | — | EP | claimed |
| US-12364682-B2 | Use of tegaserod in preparation of anti-tumor drug | QINGDAO HAIJI BIOMEDICINE CO., LTD. (CN) | 2025-07-22 | — | — | US | claimed |
| EP-0600834-A1 | Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing | CIBA-GEIGY AG (CH) | 1994-06-08 | — | — | EP | claimed |
| EP-0573604-A1 | METHODS FOR THE TREATMENT OF OSTEOPOROSIS. | NORWICH EATON PHARMA (US) | 1993-12-15 | — | — | EP | claimed |
| EP-0550385-A1 | Oral pharmaceutical compositions containing derivatives of methane-diphosphonic acid and 18-crown-6 ethers | CIBA-GEIGY AG (CH) | 1993-07-07 | — | — | EP | claimed |
| WO-1993011786-A1 | METHODS FOR THE TREATMENT OF OSTEOPOROSIS USING BISPHOSPHONATES AND PARATHYROID HORMONE | PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) | 1993-06-24 | — | — | WO | claimed |
| WO-1992014474-A1 | METHODS FOR THE TREATMENT OF OSTEOPOROSIS | NORWICH EATON PHARMACEUTICALS, INC. (US) | 1992-09-03 | — | — | WO | claimed |
| US-5133972-A | TOPICALLY ADMINISTRABLE PHARMACEUTICAL PREPARATIONS | CIBA-GEIGY CORPORATION (US) | 1992-07-28 | — | — | US | claimed |
| EP-0336851-B1 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING A DIPHOSPHONIC ACID DERIVATIVE | ELF SANOFI (FR) | 1992-03-18 | — | — | EP | claimed |
| US-4980171-A | AND SODIUM LAURYL SULFATE; EXCELLENT BIOAVAILABILITY; BONE DISORSERS, ANTIARTHRETIC | SOCIETE ANONYME DITE : SANOFI (FR) | 1990-12-25 | — | — | US | claimed |
| EP-0276288-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING A BISPHOSPHONATE AND THEIR USE FOR NASAL ADMINISTRATION | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) | 1988-08-03 | — | — | EP | claimed |
| WO-1988000829-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING A BISPHOSPHONATE AND THEIR USE FOR NASAL ADMINISTRATION | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LØVENS KEMIS (DK) | 1988-02-11 | — | — | WO | claimed |